Assignee
MINA THERAPEUTICS LTD
GB·13 granted patents·23 pending applications·17 citations·filing 2014–2023
Top patents by PatentIndex Score
36 records- 0189US10633659B2C/EBPα short activating RNA compositions and methods of useMINA THERAPEUTICS LTD·Filed 2018·Granted Apr 28, 2020·3 cites·11 claims
- 0286US9944930B2Albumin production and cell proliferationMINA THERAPEUTICS LTD·Filed 2017·Granted Apr 17, 2018·2 cites·11 claims
- 0385US11365414B2Methods of inducing insulin productionMINA THERAPEUTICS LTD·Filed 2020·Granted Jun 21, 2022·1 cites·11 claims
- 0485US9745579B2Albumin production and cell proliferationMINA THERAPEUTICS LTD·Filed 2016·Granted Aug 29, 2017·2 cites·14 claims
- 0584US10202601B2C/EBPα short activating RNA compositions and methods of useMINA THERAPEUTICS LTD·Filed 2014·Granted Feb 12, 2019·6 cites·74 claims
- 0684US2024002854A1Albumin Production and Cell ProliferationMINA THERAPEUTICS LTD·Filed 2023·Application pending·0 cites
- 0782US10704044B2Albumin production and cell proliferationMINA THERAPEUTICS LTD·Filed 2018·Granted Jul 7, 2020·1 cites·13 claims
- 0881US10912790B2C/EBP alpha saRNA compositions and methods of useMINA THERAPEUTICS LTD·Filed 2016·Granted Feb 9, 2021·2 cites·23 claims
- 0979US2024124874A1C/EBP Alpha Short Activating RNA Compositions and Methods of UseMINA THERAPEUTICS LTD·Filed 2022·Application pending·0 cites
- 1077US2022282256A1Methods of inducing insulin productionMINA THERAPEUTICS LTD·Filed 2022·Application pending·0 cites
- 1175US11965163B2HNF4a saRNA compositions and methods of useMINA THERAPEUTICS LTD·Filed 2021·Granted Apr 23, 2024·0 cites·12 claims
- 1272US2023031703A1Stabilized hnf4a sarna compositions and methods of useMINA THERAPEUTICS LTD·Filed 2022·Application pending·0 cites
- 1368US2020283771A1Albumin production and cell proliferationMINA THERAPEUTICS LTD·Filed 2020·Application pending·0 cites
- 1467US11162099B2HNF4A saRNA compositions and methods of useMINA THERAPEUTICS LTD·Filed 2018·Granted Nov 2, 2021·0 cites·4 claims
- 1567US2024018519A1Stabilized saRNA Compositions and Methods of UseMINA THERAPEUTICS LTD·Filed 2023·Application pending·0 cites
- 1665US10774331B2Methods of inducing insulin productionMINA THERAPEUTICS LTD·Filed 2017·Granted Sep 15, 2020·0 cites·11 claims
- 1764US11447773B2Stabilized HNF4A saRNA compositions and methods of useMINA THERAPEUTICS LTD·Filed 2018·Granted Sep 20, 2022·0 cites·9 claims
- 1864US9885046B2Methods of inducing insulin productionMINA THERAPEUTICS LTD·Filed 2014·Granted Feb 6, 2018·0 cites·12 claims
- 1964US2020318114A1C/ebp alpha short activating rna compositions and methods of useMINA THERAPEUTICS LTD·Filed 2020·Application pending·0 cites
- 2061US2014316126A1Rna molecules and uses thereofMINA THERAPEUTICS LTD·Filed 2014·Application pending·0 cites
- 2160US2021187007A1C/ebp alpha sarna compositions and methods of useMINA THERAPEUTICS LTD·Filed 2020·Application pending·0 cites
- 2257US2017107514A1Rna molecules and uses thereofMINA THERAPEUTICS LTD·Filed 2017·Application pending·0 cites
- 2356US2024002850A1SIRT1-saRNA Compositions and Methods of UseMINA THERAPEUTICS LTD·Filed 2022·Application pending·0 cites
- 2455US2024207304A1Combination Therapies Comprising C/EBP Alpha saRNAMINA THERAPEUTICS LTD·Filed 2022·Application pending·0 cites
- 2553US2021363525A1Sarna compositions and methods of useMINA THERAPEUTICS LTD·Filed 2021·Application pending·0 cites
- 2652US11566246B2SIRT1-saRNA compositions and methods of useMINA THERAPEUTICS LTD·Filed 2019·Granted Jan 31, 2023·0 cites·15 claims
- 2750US2020208152A1Stabilized sarna compositions and methods of useMINA THERAPEUTICS LTD·Filed 2018·Application pending·0 cites
- 2850US2024175033A1TMEM173 saRNA Compositions and Methods of UseMINA THERAPEUTICS LTD·Filed 2022·Application pending·0 cites
- 2947US2018258429A1Sarna compositions and methods of useMINA THERAPEUTICS LTD·Filed 2018·Application pending·0 cites
- 3045US2021254069A1Combination therapies comprising c/ebp alpha sarnaMINA THERAPEUTICS LTD·Filed 2019·Application pending·0 cites
- 3145US2022267770A1Compositions and methods of using c/ebp alpha sarnaMINA THERAPEUTICS LTD·Filed 2020·Application pending·0 cites
- 3244US2021024928A1C/ebp alpha sarna compositions and methods of useMINA THERAPEUTICS LTD·Filed 2019·Application pending·0 cites
- 3341US2022281911A1Oligonucleotide conjugate compositions and methods of useMINA THERAPEUTICS LTD·Filed 2020·Application pending·0 cites
- 3439US2017044540A1Sarna compositions and methods of useMINA THERAPEUTICS LTD·Filed 2015·Application pending·0 cites
- 3535US2018305689A1Sarna compositions and methods of useMINA THERAPEUTICS LTD·Filed 2016·Application pending·0 cites
- 3632US2022211740A1Sirt1-sarna compositions and methods of useMINA THERAPEUTICS LTD·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when MINA THERAPEUTICS LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →